Efficient and rapidly SCAlable EU-wide evidence-driven Pandemic response plans through dynamic Epidemic data assimilation
通过动态流行病数据同化,制定高效、快速、可扩展的欧盟范围内证据驱动的流行病应对计划
基本信息
- 批准号:10051037
- 负责人:
- 金额:$ 43.32万
- 依托单位:
- 依托单位国家:英国
- 项目类别:EU-Funded
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Pandemics have the potential to disrupt our daily lives and to affect every part of society. SARS-CoV-2 causing COVID-19 disease painfully showed how responding too late, in a fragmented mannar and/or with too little coordination across different sectors and countries, led to huge human and economic costs. ESCAPE’s main objective is to improve efficiency and scalability of early pandemic response plans by providing evidence-based guidelines, standardised research protocols, retrospective insights, and digital solutions that will support scientists in producing and integrating evidence and inform public health authorities in taking decisions to avert or reduce disease and societal burden. The project will provide knowledge and tools that will enhance Europe’s preparedness for a pandemic of pathogen X. These include a science-based blueprint for faster and better decision-making in managing pandemics, tools and frameworks to improve data availability, collection and sharing, as well as advanced analytics and models to understand and project transmission dynamics of pathogen X under candidate response scenarios. ESCAPE will also identify determinants of success and failure in managing pathogen X based on the SARS-CoV-2 pandemic, helping to develop effective response strategies for future pandemics. In addition, the project will contribute to fostering a multi-stakeholder intelligent community allowing improved knowledge sharing and cooperation between policy-makers, the scientific community, the media and the public, ensuring a much more effective response to future pandemics. In the long-term, by improving pandemic preparedness and the effectiveness of response to a pandemic of pathogen X, the project will contribute to reducing health burden and potential negative societal and economic consequences during pandemics, as well as increase the confidence of policy makers and the public in science-based solutions.
流行病有可能扰乱我们的日常生活并影响社会的各个部分,导致 COVID-19 疾病的 SARS-CoV-2 痛苦地表明,应对措施太晚、支离破碎和/或不同部门和国家之间的协调太少。 ESCAPE 的主要目标是通过提供基于证据的指南、标准化研究方案、回顾性见解和数字解决方案来提高早期大流行应对计划的效率和可扩展性,这些解决方案将支持科学家生成和整合证据和数据。通知该项目将提供知识和工具,以加强欧洲对 X 病原体大流行的准备。其中包括一个基于科学的蓝图,以便在管理方面更快、更好地做出决策。流行病、改善数据可用性、收集和共享的工具和框架,以及用于了解和预测候选应对情景下 X 病原体传播动态的高级分析和模型,还将根据情况确定管理 X 病原体成功和失败的决定因素。 SARS-CoV-2此外,该项目还将有助于培育多方利益相关者的智慧社区,改善政策制定者、科学界、媒体和公众之间的知识共享合作,确保从长远来看,通过改善大流行病的防备和应对病原体 X 大流行病的有效性,该项目将有助于减轻大流行病期间的健康负担和潜在的负面社会和经济后果。增强政策制定者和公众的信心基于科学的解决方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
Products Review
- DOI:
10.1177/216507996201000701 - 发表时间:
1962-07 - 期刊:
- 影响因子:2.6
- 作者:
- 通讯作者:
Farmers' adoption of digital technology and agricultural entrepreneurial willingness: Evidence from China
- DOI:
10.1016/j.techsoc.2023.102253 - 发表时间:
2023-04 - 期刊:
- 影响因子:9.2
- 作者:
- 通讯作者:
Digitization
- DOI:
10.1017/9781316987506.024 - 发表时间:
2019-07 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
References
- DOI:
10.1002/9781119681069.refs - 发表时间:
2019-12 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Putrescine Dihydrochloride
- DOI:
10.15227/orgsyn.036.0069 - 发表时间:
1956-01-01 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 43.32万 - 项目类别:
Studentship
相似海外基金
Two rapidly scalable, differentiated and validated COVID-19/SARS-CoV-2 antibody tests for mass-testing
两种可快速扩展、差异化且经过验证的 COVID-19/SARS-CoV-2 抗体测试,用于大规模测试
- 批准号:
75594 - 财政年份:2020
- 资助金额:
$ 43.32万 - 项目类别:
Collaborative R&D
A rapidly scalable, differentiated COVID-19 antibody/immunity test for mass-testing: proof of concept.
用于大规模测试的快速可扩展、差异化的 COVID-19 抗体/免疫测试:概念验证。
- 批准号:
56328 - 财政年份:2020
- 资助金额:
$ 43.32万 - 项目类别:
Feasibility Studies
Covid-19: a rapidly scalable SARS-Cov-2 vaccine platform based on recombinant spoke protein manufactured in insect cells using flashBAC to maximise yield and quality
Covid-19:一种快速可扩展的 SARS-Cov-2 疫苗平台,基于使用 flashBAC 在昆虫细胞中制造的重组辐条蛋白,以最大限度地提高产量和质量
- 批准号:
73370 - 财政年份:2020
- 资助金额:
$ 43.32万 - 项目类别:
Collaborative R&D
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
可快速扩展的平台,用于直接体内筛选致命癌症的功能驱动因素
- 批准号:
9902374 - 财政年份:2019
- 资助金额:
$ 43.32万 - 项目类别:
Category I: Bridges-2: Scalable Converged Computing, Data, and Analytics for Rapidly Evolving Science and Engineering Research
第一类:Bridges-2:用于快速发展的科学和工程研究的可扩展融合计算、数据和分析
- 批准号:
1928147 - 财政年份:2019
- 资助金额:
$ 43.32万 - 项目类别:
Cooperative Agreement